Journal
ANNALS OF NEUROLOGY
Volume 89, Issue 5, Pages 1041-1045Publisher
WILEY
DOI: 10.1002/ana.26041
Keywords
-
Categories
Funding
- Oswaldo Cruz Foundation
Ask authors/readers for more resources
Patients with COVID-19 may present with various neurological manifestations, with inflammatory neurological diseases associated with elevated levels of multiple cytokines in the cerebrospinal fluid, while encephalopathy is associated with increased levels of inflammatory factors in the serum.
Patients with coronavirus disease 2019 (COVID-19) can present with distinct neurological manifestations. This study shows that inflammatory neurological diseases were associated with increased levels of interleukin (IL)-2, IL-4, IL-6, IL-10, IL-12, chemokine (C-X-C motif) ligand 8 (CXCL8), and CXCL10 in the cerebrospinal fluid. Conversely, encephalopathy was associated with high serum levels of IL-6, CXCL8, and active tumor growth factor beta 1. Inflammatory syndromes of the central nervous system in COVID-19 can appear early, as a parainfectious process without significant systemic involvement, or without direct evidence of severe acute respiratory syndrome coronavirus 2 neuroinvasion. At the same time, encephalopathy is mainly influenced by peripheral events, including inflammatory cytokines. ANN NEUROL 2021
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available